Transaction DateRecipientSharesTypePriceValue
22nd December 2020Jay Venkatesan181,024Other acquisition or disposition$0.00
22nd December 2020Jay Venkatesan993,801Other acquisition or disposition$0.00
14th October 2020Bali Muralidhar200,000Open or private purchase$15.00$3,000,000.00
14th October 2020Bali Muralidhar1,592,518Conversion of derivative$0.00
6th July 2020Jay Venkatesan9,310Exercise of derivative$0.65$6,051.50
6th July 2020Jay Venkatesan12,930Exercise of derivative$1.03$13,317.90
12th June 2020Llc Aurasense10,195Open or private sale$2.83$28,851.85
12th June 2020Chad A. Mirkin10,195Open or private sale$2.83$28,851.85
20th May 2020Chad A. Mirkin49,649Exercise of derivative$0.65$32,271.85
13th March 2020David R Walt291,066Open or private purchase$1.21$352,859.31
Exicure
Exicure logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Exicure, Inc. engages in the provision of clinical stage biotechnology company. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.


Ticker: XCUR
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
SEC Central Index Key (CIK): 1698530
Employees:
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $17 M (0%)
Assets, Current: $89 M (-20%)
Property, Plant and Equipment, Net: $4 M (0%)
Other Assets, Noncurrent: $2 M (0%)
Assets: $96 M (-16%)
Long-term Debt, Current Maturities: $0 (-100%)
Accounts Payable, Current: $2 M (-15%)
Accrued Liabilities, Current: $2 M (0%)
Liabilities, Current: $14 M (-53%)
Liabilities: $14 M (-58%)
Common Stock, Value, Issued: $9 Th (0%)
Common Stock, Shares, Issued: $87 M (0%)
Retained Earnings (Accumulated Deficit): $84 M (3%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $338 Th (1151%)
Stockholders' Equity (Parent): $82 M (0%)
Liabilities and Equity: $96 M (-16%)
Revenue: $5 M (-65%)
Research and Development: $7 M (-46%)
General and Administrative Expenses: $2 M (-53%)
Operating Income/Loss: $4 M (13%)
Other Income, net: $79 Th (-88%)